Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-28

FDA Approved: FULVESTRANT — Supplemental Application (Meitheal Pharmaceuticals Inc)

View source ↗

Summary

The FDA approved a supplemental application for fulvestrant from Meitheal Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fulvestrant (fulvestrant)

Snippet

SUPPL AP for FULVESTRANT (FULVESTRANT)